Search
Peripheral Arterial Disease Clinical Trials
A listing of 38 Peripheral Arterial Disease clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 12 of 38
There are currently 38 active clinical trials seeking participants for Peripheral Arterial Disease research studies. The states with the highest number of trials for Peripheral Arterial Disease participants are Texas, Florida, California and Illinois.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Type 2 Diabetes Clinical Trial
Recruiting
Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.
Conditions:
Type 2 Diabetes
Diabetes Mellitus Type 2 in Obese
Diabetes Type Two
Type 2 Diabetes Mellitus
Diabete Type 2
Featured Trial
Crohn's Disease Clinical Study
Recruiting
Help us study a potential new way to treat Crohn's disease. We are seeking adults living with Crohn's disease to join our latest clinical trial to help us learn more. Eligible participants will receive study-related treatment, assessments, and care at no cost. You will also receive reimbursement for travel while participating. Health insurance is not required to take part.
Conditions:
Crohn's Disease
Crohn Disease
Crohns Disease
Crohn's Disease (CD)
Crohn Colitis
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention
Recruiting
This is a preliminary prospective observational study measuring change in lower extremity temperature in response to revascularization procedure.
The main question this study aims to answer is:
- Are temperature measurements from a forward looking infrared (FLIR) camera of the lower extremity useful in predicting outcome of revascularization procedures?
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
05/08/2025
Locations: University Hospitals Ahuja Medical Center, Beachwood, Ohio +2 locations
Conditions: Peripheral Arterial Disease, Critical Limb Ischemia, Critical Lower Limb Ischemia
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
Recruiting
Peripheral artery disease (PAD) is a manifestation of atherosclerosis that produces progressive narrowing and occlusion of the arteries supplying the lower extremities. The most common clinical manifestation of PAD is claudication, i.e., a severe functional limitation identified as gait dysfunction and walking-induced leg muscle pain relieved by rest. The standard therapies for claudication include the medications cilostazol and pentoxifylline, supervised exercise therapy and operative revascula... Read More
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
05/19/2025
Locations: VA Medical Center, Omaha, Nebraska
Conditions: Peripheral Arterial Disease
Effects of Carnosine In Patients With Peripheral Arterial Disease Patients
Recruiting
The purpose of this study is to determine whether carnosine (a food ingredient found in chicken and red meat) supplementation (2 g) for 6 months in participants with non-claudication and claudication peripheral arterial disease (PAD) improves walking ability. Previous studies with heart failure patients have shown that carnosine supplementation increases walking capacity in these patients.
Gender:
ALL
Ages:
Between 40 years and 80 years
Trial Updated:
05/16/2025
Locations: University of Louisville School of Medicine, Department of Medicine, Division of Environmental Medicine, Louisville, Kentucky +2 locations
Conditions: Peripheral Arterial Disease
The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)
Recruiting
The purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis \> 70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments.
Gender:
ALL
Ages:
All
Trial Updated:
05/08/2025
Locations: Salinas Valley Memorial Hospital, Salinas, California +9 locations
Conditions: Peripheral Arterial Disease, Symptomatic Femoropopliteal Lesions
Pounce™ Thrombectomy System Retrospective Registry
Recruiting
The PROWL registry is an open-label retrospective, multi-center, US study of the Surmodics™ Pounce™ Thrombectomy System for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/29/2025
Locations: OSF St. Francis Medical Center, Peoria, Illinois +8 locations
Conditions: Peripheral Arterial Disease, Acute Limb Ischemia
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
Recruiting
The purpose of this study is to develop a new noninvasive tool for early diagnosis of Peripheral Arterial Disease (PAD) and use the proposed method for monitoring the disease progression and the response to interventional treatment in PAD patients.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
04/28/2025
Locations: Mayo Clinic in Rochester, Rochester, Minnesota
Conditions: Peripheral Arterial Disease
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Recruiting
The objective of this study is to establish reasonable assurance of safety and effectiveness of the Golazo® Peripheral Atherectomy System when used as indicated in 159 subjects with symptomatic infrainguinal peripheral arterial disease (PAD) in up to 15 investigational sites in the U.S.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/14/2025
Locations: HonorHealth Scottsdale Osborn Medical Center, Scottsdale, Arizona +11 locations
Conditions: Peripheral Arterial Disease
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
Recruiting
The objective of this prospective, multicenter, randomized, controlled clinical trial is to demonstrate the superiority of the VBX Device for primary patency when compared to bare metal stenting in complex iliac occlusive disease.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/11/2025
Locations: North Suburban Medical Center, Denver, Colorado +6 locations
Conditions: Aortoiliac Occlusive Disease, Peripheral Arterial Disease
SELUTION4BTK Trial
Recruiting
This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the BTK arteries in CLTI patients.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/11/2025
Locations: St. Bernards Medical Center, Jonesboro, Arkansas +39 locations
Conditions: Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
SELUTION4SFA Trial
Recruiting
This study aims to demonstrate the safety and efficacy of the SELUTION SLR™ 018 DEB compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/11/2025
Locations: St. Bernards Medical Center, Jonesboro, Arkansas +41 locations
Conditions: Peripheral Arterial Disease, Superficial Femoral Artery Stenosis
The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
Recruiting
The purpose of this study is to understand how the drug rivaroxaban improves symptoms associated with peripheral artery disease.
Gender:
ALL
Ages:
40 years and above
Trial Updated:
03/28/2025
Locations: Vanderbilt University Medical Center, Nashville, Tennessee
Conditions: Peripheral Arterial Disease
Passive Stretching in Peripheral Arterial Disease Patients
Recruiting
Peripheral artery disease (PAD) leads to higher mortality rates and strains healthcare systems due to increased costs. It causes leg pain during walking due to reduced blood flow. Nitric oxide (NO) deficiency contributes to vascular issues in PAD, with few effective treatments available. Passive calf muscle stretching boosts NO levels, vascular health, and walking ability in PAD patients. However, the inflammatory processes underlying these improvements are unclear. This study aims to track infl... Read More
Gender:
ALL
Ages:
Between 40 years and 90 years
Trial Updated:
03/27/2025
Locations: University of Wisconsin La Crosse, La Crosse, Wisconsin
Conditions: Peripheral Arterial Disease, Walking, Difficulty, Inflammation
1 - 12 of 38